|
|||||
|
|
KE-758, an active metabolite of the new anti-rheumatic drug KE-298, suppresses production of tumor necrosis factor-alpha and interleukin-1 beta in THP-1, a human monocyte cell line |
|
| Authors: | Sugimoto M Inoue T Yamashita M Takeshita K Nakaike S |
| Affiliation: | Department of Pharmacology, Pharmaceutical Research Laboratories, Taisho Pharmaceutical Co. Ltd., Saitama, Japan. masanori.sugimoto@po.rd.taisho.co.jp |
| Abstract: | |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |